Kestra Medical Technologies, Ltd. Common Stock (KMTS) - Net Assets
Based on the latest financial reports, Kestra Medical Technologies, Ltd. Common Stock (KMTS) has net assets worth $287.99 Million USD as of January 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($379.34 Million) and total liabilities ($91.35 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check KMTS intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $287.99 Million |
| % of Total Assets | 75.92% |
| Annual Growth Rate | 121.47% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 3351.83 |
Kestra Medical Technologies, Ltd. Common Stock - Net Assets Trend (2020–2025)
This chart illustrates how Kestra Medical Technologies, Ltd. Common Stock's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Kestra Medical Technologies, Ltd. Common to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Kestra Medical Technologies, Ltd. Common Stock (2020–2025)
The table below shows the annual net assets of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025. For live valuation and market cap data, see market value of Kestra Medical Technologies, Ltd. Common.
| Year | Net Assets | Change |
|---|---|---|
| 2025-04-30 | $205.41 Million | +198.10% |
| 2024-04-30 | $-209.38 Million | -78.07% |
| 2023-04-30 | $-117.58 Million | -6757.87% |
| 2021-04-30 | $1.77 Million | -54.21% |
| 2020-04-30 | $3.86 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Kestra Medical Technologies, Ltd. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 38427000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (April 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $51.35 Million | 25.00% |
| Other Components | $674.31 Million | 328.28% |
| Total Equity | $205.41 Million | 100.00% |
Kestra Medical Technologies, Ltd. Common Stock Competitors by Market Cap
The table below lists competitors of Kestra Medical Technologies, Ltd. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tarkett SA
PA:TKTT
|
$1.11 Billion |
|
Bafang Electric Suzhou Co Ltd
SHG:603489
|
$1.11 Billion |
|
Systex Corp
TW:6214
|
$1.11 Billion |
|
Guangzhou Restaurants Group Co
SHG:603043
|
$1.11 Billion |
|
Truworths International Ltd
JSE:TRU
|
$1.11 Billion |
|
Episil-Precision Inc
TW:3016
|
$1.11 Billion |
|
Shenzhen Cotran New Material Co Ltd Class A
SHE:300731
|
$1.11 Billion |
|
SMA SOLAR T. UNSP.ADR/01
F:S93
|
$1.11 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Kestra Medical Technologies, Ltd. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -209,377,000 to 205,406,000, a change of 414,783,000.
- Net loss of 113,814,000 reduced equity.
- Dividend payments of 1,654,000 reduced retained earnings.
- New share issuances of 319,189,000 increased equity.
- Other factors increased equity by 211,062,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-113.81 Million | -55.41% |
| Dividends Paid | $1.65 Million | -0.81% |
| Share Issuances | $319.19 Million | +155.39% |
| Other Changes | $211.06 Million | +102.75% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Kestra Medical Technologies, Ltd. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.60x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 245.04x to 4.60x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-04-30 | $0.08 | $19.08 | x |
| 2021-04-30 | $0.04 | $19.08 | x |
| 2023-04-30 | $-2.37 | $19.08 | x |
| 2024-04-30 | $-4.23 | $19.08 | x |
| 2025-04-30 | $4.15 | $19.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Kestra Medical Technologies, Ltd. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -55.41%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -190.28%
- • Asset Turnover: 0.20x
- • Equity Multiplier: 1.44x
- Recent ROE (-55.41%) is above the historical average (-550.07%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -763.99% | 0.00% | 0.00x | 2.04x | $-29.85 Million |
| 2021 | -1930.97% | 0.00% | 0.00x | 17.28x | $-34.28 Million |
| 2023 | 0.00% | -1104.04% | 0.20x | 0.00x | $-72.48 Million |
| 2024 | 0.00% | -338.39% | 0.61x | 0.00x | $-73.18 Million |
| 2025 | -55.41% | -190.28% | 0.20x | 1.44x | $-134.35 Million |
Industry Comparison
This section compares Kestra Medical Technologies, Ltd. Common Stock's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,252,702,307
- Average return on equity (ROE) among peers: -94.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Kestra Medical Technologies, Ltd. Common Stock (KMTS) | $287.99 Million | -763.99% | 0.32x | $1.11 Billion |
| Akoya Biosciences Inc (AKYA) | $7.59 Million | -728.97% | 15.46x | $64.44 Million |
| Align Technology Inc (ALGN) | $-84.67 Million | 0.00% | 0.00x | $12.09 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $447.90 Million |
| AptarGroup Inc (ATR) | $2.71 Billion | 14.48% | 0.94x | $7.66 Billion |
| AtriCure Inc (ATRC) | $483.76 Million | 10.38% | 0.27x | $1.37 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.52 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $18.90 Million | -243.53% | 0.62x | $924.75 Million |
| Avantor Inc (AVTR) | $4.86 Billion | 14.14% | 1.77x | $5.44 Billion |
| Azenta Inc (AZTA) | $121.80 Million | -15.11% | 0.16x | $1.05 Billion |
| Baxter International Inc (BAX) | $4.09 Billion | 0.98% | 1.08x | $9.94 Billion |
About Kestra Medical Technologies, Ltd. Common Stock
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, thera… Read more